Fiducial Markers Market Outlook, Cost, Size, Key Vendors, Application, Trends, Competitive Landscape

A comprehensive Fiducial Markers Market report is of great importance for a better understanding of the market which leads to high business growth. This market report has a chapter on the global market and all its associated companies with their profiles, which gives valuable data related to their outlook in terms of finances, product portfolios, investment plans, and marketing and business strategies. This market research report provides important and meaningful market insights for the business by taking into consideration various factors. Thoroughly analyzed market segmentation aspect provides a clear idea about the product consumption based on several factors ranging from type, application, deployment model, end-user to geographical region.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @

Fiducial Markers Market by Product (Metal Based Markers (Gold, Gold Combination) Polymer Markers), Cancer Type (Prostate, Lung, Breast), Modality (CT, CBCT, MRI, Ultrasound), End-user (Hospitals, Outpatient Facilities) – Global Forecast to 2025 The global fiducial markers market is valued at USD 95 million in 2019 and expected to reach USD 123 million by 2025, at a CAGR of 4.5% from 2019 to 2025.

the global fiducial markers market was dominated by

  • CIVCO Radiotherapy (US),
  • IZI Medical Products (US),
  • Boston Scientific Corporation (US),
  • Naslund Medical AB (Sweden),
  • and IBA (Belgium).

Research Coverage:

The report analyzes the market for various fiducial markers and their adoption patterns. It aims at estimating the market size and future growth potential of the fiducial markers market and its sub-segments. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by top players in the fiducial markers market
  • Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and product launches in the fiducial markers market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the fiducial markers market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of leading market players.

Fiducial Markers Market Segmentation:

Fiducial Markers Market: by Product

  • Metal Based Markers (Gold, Gold Combination),
  • Polymer Markers

Fiducial Markers Market: by Cancer Type

  • Prostate,
  • Lung,
  • Breast

Fiducial Markers Market: by Modality

  • CT,
  • CBCT,
  • MRI,
  • Ultrasound

Fiducial Markers Market: by End-user

  • Hospitals,
  • Outpatient Facilities

Enquire Here for, Report Enquiry, Discount and Customization @

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data Key Data From Secondary Sources
2.1.2 Primary Data Breakdown of Primaries Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 End User-Based Market Size Estimation
2.2.3 Primary Research Validation
2.3 Market Breakdown & Data Triangulation
2.4 Assumptions for the Study
2.5 Research Limitations

3 Executive Summary

4 Premium Insights
4.1 Fiducial Markers: Market Overview
4.2 Fiducial Markers Market, By Product & Region, 2019
4.3 Market, By Modality, 2019–2025
4.4 Market, By Cancer Type, 2019 Vs. 2025
4.5 Market Share, By End User, 2019 Vs. 2025
4.6 Geographic Snapshot of the Market, 2019

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers Growing Incidence of Cancer Improving Reimbursement Scenario Rising Awareness on Radiotherapy Rising Investments and Funding for Cancer Research
5.2.2 Restraints Lack of Adequate Healthcare Infrastructure and Premium Pricing of Modalities Alternative Therapies and High Marker Costs
5.2.3 Opportunities Emerging Economies
5.2.4 Challenges Complications Associated With the Placement of Fiducial Markers Shortage of Trained Personnel

6 Market, By Product
6.1 Introduction
6.2 Metal-Based Markers
6.2.1 Pure Gold Markers Pure Gold Markers Hold the Largest Share of the Metal-Based Market
6.2.2 Gold Combination Markers High-Precision Advantages and Versatility are Driving Demand for Gold Combination Markers
6.2.3 Other Metal-Based Markers
6.3 Polymer-Based Markers
6.3.1 Visibility Limitations Have Affected Demand for Polymer-Based Markers
6.4 Other Fiducial Markers

7 Market, By Modality
7.1 Introduction
7.2 Ct/Cbct
7.2.1 Technological Advancements and Rising Adoption of Cbct are Expected to Fuel Market Growth
7.3 Ultrasound
7.3.1 Rising Preference for Minimally Invasive Procedures is Driving Demand for Ultrasound
7.4 MRI
7.4.1 High Adoption of Combined Ct-Mri Modalities for Fm Localization Will Drive Segmental Growth
7.5 Radiotherapy
7.5.1 High Success Rate of Sbrt Using Radiotherapy Systems Will Drive the Segment Growth

8 Market, By Cancer Type
8.1 Introduction
8.2 Prostate Cancer
8.2.1 Prostate Cancer Holds the Largest Share of the Market, By Cancer Type
8.3 Lung Cancer
8.3.1 Technological Advancements and Product Approvals Will Drive Market Growth
8.4 Gastric Cancer
8.4.1 High Incidence of Gastric Cancer and Advancements in Treatment Support Market Growth
8.5 Breast Cancer
8.5.1 EffiCACy of Advanced Radiology Treatment for Breast Cancer Will Ensure the Growth of the Market
8.6 Other Cancers

9 Market, By End User
9.1 Introduction
9.2 Hospitals & Outpatient Facilities
9.2.1 Hospitals & Outpatient Facilities Hold the Largest Share of the Market
9.3 Independent Radiotherapy Centers
9.3.1 Unfavorable Reimbursement Scenario Will Hamper Growth
9.4 Cancer Research Centers
9.4.1 Rising Investments and Funding Will Increase Research Activities and Support Market Growth

10 Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US US Commanded the Largest Share of the Market in 2018
10.2.2 Canada Public-Private Initiatives are Expected to Support the Adoption of Radiotherapy Procedures and Fiducial Markers
10.3 Europe
10.3.1 Germany Favorable Reimbursement Scenario for Radiotherapy is Supporting Market Growth in Germany
10.3.2 UK Rising Cancer Incidence and the Presence of Highly Developed Healthcare Infrastructure are Supporting Market Growth in the UK
10.3.3 France Increasing Access to Radiotherapy Will Drive Market Growth
10.3.4 Spain Shortage of Human Resources and Lack of Accessibility May Hinder Market Growth
10.3.5 Italy Rising Research Activities Will Support Market Growth
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan Japan Dominates the APAC Market
10.4.2 China China Will Register the Highest Growth in the APAC Market Due to the Growing Target Patient Population
10.4.3 India Indian Market is Expected to be Driven By the Surge in Patient Population and Favorable Government Initiatives
10.4.4 South Korea Growing Adoption of Advanced EBRT is Contributing to Market Growth in the Country
10.4.5 Australia Favorable Reimbursement Scenario Will Support Market Growth
10.4.6 Rest of APAC
10.5 Latin America
10.5.1 Brazil Brazil Held the Largest Share of the Latin American Market in 2018
10.5.2 Mexico Initiatives are Being Undertaken to Spread Awareness and Boost Access to Radiotherapy
10.5.3 Rest of Latam
10.6 Middle East & Africa
10.6.1 Poor Healthcare Infrastructure and Reimbursement Scenario Restrain Market Growth

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Scenario
11.3.1 Key Product Launches and Enhancements
11.3.2 Key Agreements, Partnerships, and Collaborations
11.3.3 Key Acquisitions
11.3.4 Key Expansions
11.4 Competitive Leadership Mapping
11.4.1 Visionary Leaders
11.4.2 Innovators
11.4.3 Dynamic Differentiators
11.4.4 Emerging Companies

12 Company Profiles

Get Discount on the Latest Report @

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact Us:

Corporate Headquarters

Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India

 + 1 888 391 5441
 [email protected]

Share This Post